MX9700885A - Nuevas heteroariloxazolidinonas. - Google Patents
Nuevas heteroariloxazolidinonas.Info
- Publication number
- MX9700885A MX9700885A MX9700885A MX9700885A MX9700885A MX 9700885 A MX9700885 A MX 9700885A MX 9700885 A MX9700885 A MX 9700885A MX 9700885 A MX9700885 A MX 9700885A MX 9700885 A MX9700885 A MX 9700885A
- Authority
- MX
- Mexico
- Prior art keywords
- heteroaryloxazolidinones
- new
- substituents
- cited
- procedure
- Prior art date
Links
- 229940124350 antibacterial drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13003—Constructional details of switching devices
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13196—Connection circuit/link/trunk/junction, bridge, router, gateway
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13202—Network termination [NT]
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13203—Exchange termination [ET]
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13209—ISDN
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/1329—Asynchronous transfer mode, ATM
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13292—Time division multiplexing, TDM
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2213/00—Indexing scheme relating to selecting arrangements in general and for multiplex systems
- H04Q2213/13299—Bus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La invencion hace referencia a nuevas heteroariloxazolidinonas de formula general (I) en la que los sustituyentes son lo que se ha citado en la descripcion, a un procedimiento para su preparacion y su uso como fármaco, antibacteriano.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19604224 | 1996-02-06 | ||
| DE19604224.0 | 1996-02-06 | ||
| DE19649095.2 | 1996-11-27 | ||
| DE19649095A DE19649095A1 (de) | 1996-02-06 | 1996-11-27 | Neue Heteroaryl-Oxazolidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97000885A MXPA97000885A (es) | 1998-04-01 |
| MX9700885A true MX9700885A (es) | 1998-04-30 |
Family
ID=26022660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9700885A MX9700885A (es) | 1996-02-06 | 1997-02-04 | Nuevas heteroariloxazolidinonas. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5922708A (es) |
| EP (1) | EP0789026A1 (es) |
| JP (1) | JPH101480A (es) |
| AU (1) | AU1251797A (es) |
| BG (1) | BG101194A (es) |
| BR (1) | BR9700903A (es) |
| CA (1) | CA2196859A1 (es) |
| CZ (1) | CZ34197A3 (es) |
| EE (1) | EE9700044A (es) |
| HR (1) | HRP970049A2 (es) |
| HU (1) | HUP9700328A3 (es) |
| ID (1) | ID15880A (es) |
| IL (1) | IL120124A0 (es) |
| MX (1) | MX9700885A (es) |
| NO (1) | NO970512L (es) |
| NZ (1) | NZ314178A (es) |
| PL (1) | PL318278A1 (es) |
| SG (1) | SG60040A1 (es) |
| SK (1) | SK15797A3 (es) |
| TR (1) | TR199700090A2 (es) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
| GB9717807D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
| GB9717804D0 (en) * | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
| WO1999012914A1 (en) * | 1997-09-11 | 1999-03-18 | Hokuriku Seiyaku Co., Ltd. | Thiourea derivatives |
| GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
| US6562844B2 (en) | 1998-01-23 | 2003-05-13 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| US7002020B1 (en) | 1998-01-23 | 2006-02-21 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| CN1288462A (zh) | 1998-01-23 | 2001-03-21 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮组合库、组合物和制备方法 |
| WO1999064417A2 (en) | 1998-06-05 | 1999-12-16 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| AU773359B2 (en) | 1999-07-28 | 2004-05-20 | Pharmacia & Upjohn Company | Oxazolidinones and their use as antiinfectives |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| KR100731469B1 (ko) * | 2000-06-05 | 2007-06-21 | 동아제약주식회사 | 피리딘 고리를 포함하는 옥사졸리디논 유도체 및 그의제조방법 |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| MXPA05013132A (es) | 2003-06-03 | 2006-05-25 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos de biarilo y metodos de produccion y su uso. |
| US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| JP2007514782A (ja) * | 2003-12-17 | 2007-06-07 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法 |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (en) * | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
| JP5534497B2 (ja) | 2005-06-08 | 2014-07-02 | メリンタ セラピューティクス,インコーポレイテッド | トリアゾール類の合成方法 |
| JP5214096B2 (ja) * | 2005-06-17 | 2013-06-19 | 富士フイルムファインケミカルズ株式会社 | 新規なビピリジン誘導体 |
| DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| PT1934208E (pt) | 2005-10-04 | 2011-06-01 | Bayer Schering Pharma Ag | Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
| US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| US7652018B2 (en) * | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| US20100234390A1 (en) * | 2007-06-22 | 2010-09-16 | Simi Pushpan | Novel compound and their use |
| CN103289038B (zh) * | 2013-06-14 | 2014-10-01 | 四川大学 | 星型噁唑烷潜固化剂及其制备方法和用途 |
| WO2018170664A1 (en) | 2017-03-20 | 2018-09-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
| US4921869A (en) * | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US4965268A (en) * | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US5032605A (en) * | 1987-10-09 | 1991-07-16 | Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents |
| US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US4942183A (en) * | 1987-10-16 | 1990-07-17 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| CA1320730C (en) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| US5254577A (en) | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5130316A (en) * | 1988-07-29 | 1992-07-14 | Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents |
| US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| ATE112773T1 (de) | 1988-09-15 | 1994-10-15 | Upjohn Co | 5-indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(nitrogen- substituierte)phenyl-5-beta-amidomethyloxazolid n-2-one. |
| US5225565A (en) * | 1988-09-15 | 1993-07-06 | The Upjohn Company | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones |
| US5182403A (en) * | 1988-09-15 | 1993-01-26 | The Upjohn Company | Substituted 3(5'indazolyl) oxazolidin-2-ones |
| JP2669579B2 (ja) * | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
| CA2119556C (en) * | 1991-11-01 | 2004-07-06 | Michael Robert Barbachyn | Substituted aryl- and heteroaryl-phenyloxazolidinones |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
| TW286317B (es) * | 1993-12-13 | 1996-09-21 | Hoffmann La Roche | |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425609A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
-
1997
- 1997-01-24 HR HR19649095.2A patent/HRP970049A2/hr not_active Application Discontinuation
- 1997-01-31 EP EP97101510A patent/EP0789026A1/de not_active Withdrawn
- 1997-02-03 HU HU9700328A patent/HUP9700328A3/hu unknown
- 1997-02-03 US US08/790,869 patent/US5922708A/en not_active Expired - Fee Related
- 1997-02-03 IL IL12012497A patent/IL120124A0/xx unknown
- 1997-02-03 NZ NZ314178A patent/NZ314178A/xx unknown
- 1997-02-04 ID IDP970339A patent/ID15880A/id unknown
- 1997-02-04 BG BG101194A patent/BG101194A/xx unknown
- 1997-02-04 PL PL97318278A patent/PL318278A1/xx unknown
- 1997-02-04 AU AU12517/97A patent/AU1251797A/en not_active Abandoned
- 1997-02-04 MX MX9700885A patent/MX9700885A/es unknown
- 1997-02-05 NO NO970512A patent/NO970512L/no unknown
- 1997-02-05 TR TR97/00090A patent/TR199700090A2/xx unknown
- 1997-02-05 EE EE9700044A patent/EE9700044A/xx unknown
- 1997-02-05 CZ CZ97341A patent/CZ34197A3/cs unknown
- 1997-02-05 SG SG1997000258A patent/SG60040A1/en unknown
- 1997-02-05 CA CA002196859A patent/CA2196859A1/en not_active Abandoned
- 1997-02-05 SK SK157-97A patent/SK15797A3/sk unknown
- 1997-02-06 JP JP9036901A patent/JPH101480A/ja active Pending
- 1997-02-06 BR BR9700903A patent/BR9700903A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9700328A3 (en) | 1998-09-28 |
| HU9700328D0 (en) | 1997-03-28 |
| TR199700090A2 (tr) | 1997-08-21 |
| PL318278A1 (en) | 1997-08-18 |
| US5922708A (en) | 1999-07-13 |
| JPH101480A (ja) | 1998-01-06 |
| CZ34197A3 (en) | 1997-08-13 |
| BG101194A (en) | 1998-04-30 |
| IL120124A0 (en) | 1997-06-10 |
| NO970512L (no) | 1997-08-07 |
| NZ314178A (en) | 1998-12-23 |
| CA2196859A1 (en) | 1997-08-07 |
| ID15880A (id) | 1997-08-14 |
| NO970512D0 (no) | 1997-02-05 |
| EP0789026A1 (de) | 1997-08-13 |
| AU1251797A (en) | 1997-08-14 |
| HRP970049A2 (en) | 1998-04-30 |
| SG60040A1 (en) | 1999-02-22 |
| BR9700903A (pt) | 1998-08-18 |
| HUP9700328A2 (hu) | 1998-08-28 |
| SK15797A3 (en) | 1997-10-08 |
| EE9700044A (et) | 1997-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700885A (es) | Nuevas heteroariloxazolidinonas. | |
| MX9700886A (es) | Nuevas oxazolidinonas sustituidas. | |
| ZA9710796B (en) | Oxyiminopregnanecarbolactones. | |
| AU5554198A (en) | 3-thiocarbamoylpyrazole derivatives as pesticides | |
| SE9504661D0 (sv) | New compounds | |
| WO1996032003A3 (en) | Tetrahydroimidazopyridoindolediones and their use as medicaments | |
| SE9704545D0 (sv) | Novel compounds | |
| SE9704544D0 (sv) | Novel compounds | |
| BG104056A (en) | Triazole compounds and their use as dopamine-d3-ligands | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| IL114294A0 (en) | Sterol derivatives | |
| CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| IT1285770B1 (it) | Composti corticoidei | |
| AU3850600A (en) | Dalda analogs and their use | |
| SE9802208D0 (sv) | Novel compounds | |
| MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
| BG102623A (bg) | Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства | |
| MX9803672A (es) | Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos. | |
| MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
| MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
| MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
| SE9802209D0 (sv) | Novel compounds | |
| SE9504662D0 (sv) | New compounds | |
| IN187760B (es) |